Cost-Effectiveness Analysis of the Use of a Prophylactic Antibiotic for Patients Undergoing Lower Limb Amputation due to Diabetes or Vascular Illness in Colombia
Background The use of a prophylactic antibiotic in an amputation surgery is a key element for the successful recovery of the patient. We aim to determine, from the perspective of the Colombian health system, the cost-effectiveness of administering a prophylactic antibiotic among patients undergoing...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22489
- Acceso en línea:
- https://doi.org/10.1016/j.avsg.2016.07.090
https://repository.urosario.edu.co/handle/10336/22489
- Palabra clave:
- Antibiotic agent
Cefalotin
Cefazolin
Cefotaxime
Cefoxitin
Cefuroxime
Cephalosporin
Meropenem
Piperacillin plus tazobactam
Vancomycin
Antiinfective agent
Antibiotic prophylaxis
Below knee amputation
Colombia
Comparative study
Cost effectiveness analysis
Deep infection
Diabetes mellitus
Drug cost
Drug utilization
Postoperative infection
Priority journal
Review
Sepsis
Superficial infection
Surgical mortality
Surgical patient
Vascular disease
Amputation
Antibiotic prophylaxis
Cost benefit analysis
Decision support system
Decision tree
Diabetic angiopathy
Drug administration
Economic model
Economics
Human
Lower limb
Microbiology
Mortality
Peripheral vascular disease
Surgical infection
Treatment outcome
Vascularization
Amputation
Anti-bacterial agents
Antibiotic prophylaxis
Colombia
Cost-benefit analysis
Decision support techniques
Decision trees
Diabetic angiopathies
Drug administration schedule
Drug costs
Humans
Lower extremity
Peripheral vascular diseases
Surgical wound infection
Treatment outcome
economic
Models
- Rights
- License
- Abierto (Texto Completo)